9-ING-41 in Patients With Advanced Cancers
Actuate Therapeutics Inc.
Actuate Therapeutics Inc.
Incyte Corporation
Cyteir Therapeutics, Inc.
Eli Lilly and Company
Syros Pharmaceuticals
Incyte Corporation
Gilead Sciences
University of Maryland, Baltimore
Eli Lilly and Company
Celgene
Western Regional Medical Center
Masonic Cancer Center, University of Minnesota
Northwestern University
Altor BioScience
Dartmouth-Hitchcock Medical Center
National Cancer Institute (NCI)
National University Hospital, Singapore